• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,666
303
265
201
170

COUNTRY

87
40
39
39
38

CATEGORIES

  • 1,209
  • 920
  • 782
  • 294
  • 286
  • 240
  • 213
  • 185
  • 156
  • 131
  • 123
  • 107
  • 91
  • 61
  • 50
  • 43
  • 43
  • 39
  • 38
  • 36
  • 26
  • 23
  • 20
  • 20
  • 16
  • 13
  • 10
  • 9
  • 9
  • 9
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

941
1,784
2,942
4,084

PUBLISHED

162
261
784
4,084

PRODUCT TYPE

3,739
170
137
31
6
1

Search "Company Analysis - Novartis AG" returned 4,084 results.

Novartis AG (NOVN) - Product Pipeline Analysis, 2014 Update

Summary Novartis AG (Novartis) is a healthcare solutions company. It undertakes the discovery, development and commercialization of a wide range of novel and generic products across various therapeutic...

May 2014
FROM

Novartis AG Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Novartis AG Company Profile” is a comprehensive report on Novartis AG. The report provides complete information on the operations, organization structure and financial information details of the company....

October 2014
FROM

Novartis AG: Corporate Analysis

This company profile is a premium company information product offering an unmatched depth and breadth of content. It analyzes the strategic positioning of the company - how the company has evolved and...

July 2010
FROM

Novartis AG - Product Pipeline Review - 2014

Novartis AG - Product Pipeline Review - 2014 Summary This, ‘Novartis AG - Product Pipeline Review - 2014’, provides an overview of the Novartis AG’s pharmaceutical research and development focus. This...

September 2014
FROM

Novartis AG - Strategy and SWOT Report

Novartis AG - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

December 2014
FROM

Novartis AG - Product Pipeline Review - 2013

Novartis AG – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Novartis AG - Product Pipeline Review - 2013” provides data on the Novartis AG’s research and development...

April 2013
FROM

Novartis AG - SWOT, Strategy and Corporate Finance Report

Novartis AG - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

June 2013
FROM

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

April 2015
FROM

Novartis AG - Product Pipeline Review - 2012

Novartis AG – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Novartis AG - Product Pipeline Review - 2012” provides data on the Novartis AG’s research and development...

November 2012
FROM
Top Five Generic Drugs Companies: Performance, Strategies and Competitive Analysis Top Five Generic Drugs Companies: Performance, Strategies and Competitive Analysis - Product Thumbnail Image

Top Five Generic Drugs Companies: Performance, Strategies and Competitive Analysis

Top companies are making strategic acquisitions to expand their global footprint, together with taking advantage of established business and expertise gained through the acquired company The global...

March 2013
FROM

US OTC Pharmaceutical Market Guide

The US OTC industry is expected to have a market value of $31 9 billion by the end of 2014 In this reserach report, you'll learn about the U S OTC Pharmaceutical Market's competitive landscape, market...

November 2012
FROM

Global Transdermal Drug Delivery Market 2014-2018

About Transdermal Drug Delivery Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin...

June 2014
FROM

Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis

The global pharmaceutical industry is expected to reach $1,241 billion by 2016, growing at a CAGR of 5 7% The fragmented market has observed some changes in the competitive landscape during the last...

December 2012
FROM

Human Vaccine Technologies Market

Immunization is one of the highest impact and most cost effective methods of preventing infectious diseases, particularly in low and middle income countries with minimal healthcare facilities in remote...

August 2015
FROM

Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer...

February 2015
FROM

Meningococcal Meningitis - Pipeline Review, H2 2013

Meningococcal Meningitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Meningococcal Meningitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Global Travel Vaccines Market 2015-2019

About Travel Vaccines Vaccines are biological preparations that provide immunity to a particular disease by stimulating the immune system. The vaccines can be administered orally, intra-nasally, or...

March 2015
FROM

Novartis AG Apr 14

Abstract Our 'AA-' rating on Novartis AG is derived from: Our anchor of 'aa+', based on our "excellent" business risk and "minimal" financial risk profile assessments for the company. A downward adjustment...

April 2014

Multiple Sclerosis Market in the US 2015-2019

About Multiple Sclerosis Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and...

July 2015
FROM

Global Diabetic Retinopathy Market 2015-2019

About Diabetic Retinopathy Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images...

May 2015
FROM
Loading Indicator

Our Clients

Intel Corporation Autodesk, Inc. Hewlett-Packard Company Ahlstrom Corporation SAP SE 3M Company Samsung Group Ltd.